MetLife Investment Management’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,977
| Closed | -$160K | – | 2768 |
|
|
2021
Q4 | $160K | Hold |
9,977
| – | – | ﹤0.01% | 2193 |
|
|
2021
Q3 | $184K | Hold |
9,977
| – | – | ﹤0.01% | 2152 |
|
|
2021
Q2 | $139K | Buy |
9,977
+7,949
| +392% | +$111K | ﹤0.01% | 2356 |
|
|
2021
Q1 | $29.9K | Sell |
2,028
-7,402
| -78% | -$109K | ﹤0.01% | 2295 |
|
|
2020
Q4 | $183K | Buy |
+9,430
| New | +$183K | ﹤0.01% | 2028 |
|
|
2020
Q3 | – | Sell |
-7,571
| Closed | -$102K | – | 2333 |
|
|
2020
Q2 | $102K | Buy |
+7,571
| New | +$102K | ﹤0.01% | 2246 |
|